Choosing Treatment: Matching Needs to Therapy

This activity is part of a series


Michael J. Thorpy, MD
Professor of Neurology, Albert Einstein College of Medicine
Director, Sleep-Wake Disorders Center, Department of Neurology
Montefiore Medical Center, Bronx, NY
President, New York State Society of Sleep Medicine
Past President, Sleep Section of the Academy of Neurology
Michael J. Thorpy, MD

Dr. Thorpy is a Professor of Neurology at Albert Einstein College of Medicine and Director of the Sleep-Wake Disorders Center in the Department of Neurology at Montefiore Medical Center, both in New York. In addition to treating patients with sleep disorders, he conducts research in narcolepsy, insomnia, and sleep apnea. He is President of the New York State Society of Sleep Medicine, Past President of the Sleep Section of the Academy of Neurology, and Past Secretary of the National Sleep Foundation. In 1993 Dr. Thorpy received the Nathaniel Kleitman Award from the American Academy of Sleep Medicine, one of the field’s highest honors, and in 2012 he received the Lifetime Achievement Award from the National Sleep Foundation.

Born in New Zealand, Dr. Thorpy earned his medical degree from the University of Otago Medical School. After receiving postgraduate training in Dunedin, New Zealand; Bombay, India; and London, England, he completed his residency in neurology at the State University of New York in Syracuse and a neuroendocrinology fellowship at Albert Einstein College of Medicine and Montefiore Medical Center. Dr. Thorpy is board certified in sleep medicine.

He has published extensively on narcolepsy, insomnia, and sleep disorders. He chaired the first International Classification of Sleep Disorders and has published more than 250 peer-reviewed articles and chapters, including publications in journals such as The New England Journal of Medicine. His numerous books include The Encyclopedia of Sleep and Sleep Disorders, Parasomnias (2010), Sleepiness (2011), Neuroimaging of Sleep and Sleep Disorders (2012), Genetics of Sleep and Sleep Disorders (2013), Narcolepsy: a Clinical Guide (2016), and SleepMultiMedia, The Computerized Textbook of Sleep Medicine (v12).0 (2023).

Dr. Thorpy has given more than 100 television, radio, and print interviews on sleep disorders.

R. Robert Auger, MD, FAASM, FAPA, DABPN
Mayo Center for Sleep Medicine
Associate Professor of Psychiatry & Medicine
Department of Psychiatry & Psychology
Mayo Clinic College of Medicine and Science
Rochester, MN
R. Robert Auger, MD, FAASM, FAPA, DABPN

Dr. R. Robert Auger is a consultant in Mayo Clinic’s Center for Sleep Medicine with wide-ranging interests in the field, particularly with respect to circadian rhythm sleep-wake disorders and disorders of hypersomnolence.  He is one of only several sleep medicine physicians who interfaces with the adolescent population. After receiving his medical degree from the University of Minnesota Medical School, Dr. Auger completed internship and residency at Johns Hopkins in Baltimore. Following his Sleep Medicine Fellowship at Mayo Clinic, he then joined the staff with a joint appointment in Sleep Medicine and Psychiatry & Psychology.

Dr. Auger has served as Chair of the American Academy of Sleep Medicine’s (AASM) Circadian Rhythm Membership Section, the Circadian Rhythm Sleep Disorders Practice Parameters Update Task Force, and of the Circadian Rhythm Sleep-Wake Disorders Work Group for revision of the International Classification of Sleep Disorders. He has also participated in AASM Hypersomnia Practice Guideline Task Forces. He recently edited the book “Circadian Rhythm Sleep-Wake Disorders: An Evidence-Based Guide for Clinicians and Investigators.”

Farah Hasan, Hons BSc
Expert Advisory Board Member & Rising Voices Speaker, Project Sleep
Graduate Student, Health Science Education, McMaster University
Scholar and Graduate Fellow, McMaster Education Research, Innovation and Theory (MERIT) Program
Hamilton, Ontario, Canada
Farah Hasan, Hons BSc

Farah Hasan received a BSc in Biology and Psychology, Neuroscience and Behaviour from McMaster University in Hamilton, Ontario, Canada. She is currently pursuing an MSc in the Health Science Education Graduate Program at McMaster, and she is a Graduate Scholar and Fellow of the McMaster Education Research, Innovation and Theory (MERIT) Program. Her research explores the efficacy of a virtual reality application for teaching anatomy.

Farah sits on the Expert Advisory Board for Project Sleep as a patient advocate. She is also a trained speaker with the Rising Voices program and engages diverse audiences and communities through advocacy presentations and talks, sharing her experience as a person living with idiopathic hypersomnia.



Statement of Need

Idiopathic hypersomnia (IH) is an elusive disease state with a significant impact on quality of life (QoL). Clinicians often fail to recognize how this impact on QoL affects both patient and family, and how IH disrupts one’s ability to live a full life. Unfortunately, clinician’s struggle to apply novel treatments into practice and lack guidance as recent AASM guidelines to not include most up-to-date data for the optimal treatment of IH. Additionally, in August 2021, lower-sodium oxybate (LXB) was the first treatment approved for IH, however, understanding of this novel treatment is still lacking.

In this CMEO BriefCase entitled, Choosing Treatment: Matching Needs to Therapy, expert faculty will engage in a case-based discussion on how to best utilize the latest efficacy and safety data to integrate novel therapies into clinical practice to mitigate the impact of IH.

Learning Objective

Utilize the latest efficacy and safety data to integrate novel therapies into clinical practice to mitigate the impact of IH.

Financial Support

This program is supported by an independent medical education grant from Jazz Pharmaceuticals.

Target Audience

Sleep specialists, primary care physicians, pulmonologists, neurologists, psychiatrists, physician associates (PAs), nurse practitioners (NPs), nurses, and pharmacists.

Credit Information

Jointly Accredited Provider

In support of improving patient care, CME Outfitters, LLC, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Interprofessional (IPCE) 0.5

This activity was planned by and for the healthcare team, and learners will receive 0.5 Interprofessional Continuing Education (IPCE) Credit for learning and change.

Physicians (ACCME) 0.5

CME Outfitters, LLC, designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses (ANCC) 0.5

This activity is designated for 0.5 contact hours.

Note for California Nurses

This continuing nursing education activity was approved by the California Board of Registered Nursing. CME Outfitters, LLC’s provider number is CEP15510.

Pharmacists (ACPE) 0.5

This application-based activity is approved for 0.5 contact hours (0.05 CEUs) of continuing pharmacy credit.
Activity UAN: JA0007185-0000-23-078-H01-P

Physician Assistants (AAPA): 0.5

CME Outfitters, LLC, has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.5 AAPA Category 1 CME credits. Approval is valid until expiration date listed above. PAs should only claim credit commensurate with the extent of their participation.


Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.5 medical knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

MIPS Improvement Activity

Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.

Royal College MOC

Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process.

Dr. Thorpy reports the following financial relationships:

Advisory Board/Consultant: Alkermes; Axsome Therapeutics, Inc.; Balance Therapeutics; Eisai Inc.; Flamel Technologies/Avadel; Harmony Biosciences; Idorsia Pharmaceuticals Ltd; Jazz Pharmaceuticals, Inc.; NLS Pharmaceutics; Suven Life Sciences Ltd.; Takeda Pharmaceuticals U.S.A., Inc.; and XWPharma Ltd.

Dr. Auger has no financial relationships to disclose.

Ms. Hasan has no financial relationships to disclose.

Disclosures were obtained from the CME Outfitters, LLC staff; no disclosures to report:

  • Christina Rivera Carpenter, PhD, RN (peer reviewer)
  • Evan Luberger (planning committee)
  • John Jones, PharmD (planning committee)
  • Susan H. Yarbrough, CHCP (planning committee)
  • Sandra Caballero, PharmD (planning committee)
  • Sharon Tordoff (planning committee)

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Obtaining Credit

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit our Privacy & Confidentiality page.

Questions about this activity?

Call us at 877.CME.PROS (877.263.7767).


Choosing Treatment: Matching Needs to Therapy
Event Date: 07/24/2023 at 4:00 am EST